Log In
BCIQ
Print this Print this
 

itruglumide (CR2945)

  Manage Alerts
Collapse Summary General Information
Company Rottapharm Biotech s.r.l.
DescriptionCCK-2 receptor antagonist
Molecular Target Cholecystokinin B receptor (CCKBR) (CCK2R)
Mechanism of ActionCholecystokinin B receptor antagonist
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today